Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANTXR like pseudogene 1 (ANTXRLP1)
- Target
- ANTXRLP1
- Molecular classification
- Other (Pseudogene)
01
Overview
ANTXR like pseudogene 1 (ANTXRLP1) is a human genomic sequence classified as a pseudogene, meaning it resembles a functional gene (in this case, likely related to the anthrax toxin receptor/ANTXR family) but contains disabling mutations such as frameshifts or stop codons that prevent it from encoding a functional protein. No evidence currently suggests it has an active biological function or clinical relevance as a biomarker or therapeutic target. Some pseudogenes are transcribed and may have regulatory RNA functions; however, there is no specific evidence for such a role for ANTXRLP1.
02
Mechanism of action
Not applicable; there are no drugs targeting ANTXRLP1.
03
Biological functions
There are no established protein-level biological functions for ANTXRLP1; like other pseudogenes, it could theoretically participate in RNA-based regulatory processes, but no function has been demonstrated for this specific pseudogene.
04
Disease associations
None known or established for ANTXRLP1; most pseudogenes have no direct role in disease, though some may have regulatory effects
05
Safety considerations
None, as it is not a therapeutic target and has no described biological activity.
Beyond the preview
Go deeper on ANTXR like pseudogene 1 (ANTXRLP1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ANTXR like pseudogene 1 (ANTXRLP1).